Harpoon Therapeutics Inc (DELISTED) (HARP:DL)
23.01
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
Harpoon Therapeutics Total Liabilities (Quarterly): 43.04M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 43.04M |
| June 30, 2023 | 60.20M |
| March 31, 2023 | 80.09M |
| December 31, 2022 | 68.33M |
| September 30, 2022 | 66.58M |
| June 30, 2022 | 82.31M |
| March 31, 2022 | 91.06M |
| December 31, 2021 | 97.38M |
| September 30, 2021 | 97.70M |
| June 30, 2021 | 105.25M |
| March 31, 2021 | 158.94M |
| Date | Value |
|---|---|
| December 31, 2020 | 117.75M |
| September 30, 2020 | 122.58M |
| June 30, 2020 | 125.22M |
| March 31, 2020 | 79.20M |
| December 31, 2019 | 82.38M |
| September 30, 2019 | 35.16M |
| June 30, 2019 | 34.54M |
| March 31, 2019 | 33.34M |
| December 31, 2018 | 156.06M |
| September 30, 2018 | 76.29M |
| December 31, 2017 | 58.82M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
34.54M
Minimum
Jun 2019
158.94M
Maximum
Mar 2021
85.98M
Average
82.35M
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co Inc | 65.42B |
| Axonics Inc | 88.46M |
| Johnson & Johnson | 101.95B |
| Boston Scientific Corp | 16.50B |
| Ambrx Biopharma Inc (DELISTED) | 29.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 47.58M |
| Shareholders Equity (Quarterly) | 4.541M |
| Current Ratio | 1.894 |